Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity.
Farhat-Younis L, Na M, Zarfin A, Khateeb A, Santana-Magal N, Richter A, Gutwillig A, Rasoulouniriana D, Gleiberman A, Beck L, et al. Elife. 2024 Jun 17; 12. Epub 2024 Jun 17.